10x Genomics, Inc. · NASDAQ:TXG

Stuelpnagel John R sold 20,000 10x Genomics, Inc. shares (Form 4)

Traded Aug 11, 2026 · Filed Aug 13, 2026

On Aug 11, 2026, Stuelpnagel John R (Director) sold 20,000 10x Genomics, Inc. shares at an average US$57.75 for US$1.16M, leaving 348,436 shares. Filed Aug 13, 2026 (Form 4).

Sold
20,000 shares
Price
US$57.75 average (US$57.58 to US$58.73)
Value
US$1.16M
Holding after
348,436 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 11, 2026Class A Common StockSale17,000US$57.58351,436Direct
Aug 11, 2026Class A Common StockSale3,000US$58.73348,436Direct

Source

View original at SEC

Related